Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-09 to 2023-01-10
Current total value of award: $8.4
Description: 4559600586!GLIPIZIDE XL 2.5 MG TABLET 30S